rs137853260
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000276.4(OCRL):c.1499G>A(p.Arg500Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R500G) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000276.4 missense
Scores
Clinical Significance
Conservation
Publications
- Dent disease type 2Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, G2P, Laboratory for Molecular Medicine, Orphanet, Labcorp Genetics (formerly Invitae)
- oculocerebrorenal syndromeInheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, ClinGen, Orphanet, Laboratory for Molecular Medicine
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_000276.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| OCRL | NM_000276.4 | MANE Select | c.1499G>A | p.Arg500Gln | missense | Exon 15 of 24 | NP_000267.2 | ||
| OCRL | NM_001318784.2 | c.1502G>A | p.Arg501Gln | missense | Exon 15 of 24 | NP_001305713.1 | |||
| OCRL | NM_001587.4 | c.1499G>A | p.Arg500Gln | missense | Exon 15 of 23 | NP_001578.2 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| OCRL | ENST00000371113.9 | TSL:1 MANE Select | c.1499G>A | p.Arg500Gln | missense | Exon 15 of 24 | ENSP00000360154.4 | ||
| OCRL | ENST00000357121.5 | TSL:1 | c.1499G>A | p.Arg500Gln | missense | Exon 15 of 23 | ENSP00000349635.5 | ||
| OCRL | ENST00000646010.1 | n.*1338G>A | non_coding_transcript_exon | Exon 16 of 25 | ENSP00000494940.1 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Lowe syndrome Pathogenic:3Other:1
This sequence change replaces arginine, which is basic and polar, with glutamine, which is neutral and polar, at codon 500 of the OCRL protein (p.Arg500Gln). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with Lowe syndrome (PMID: 25480730, 35919034). ClinVar contains an entry for this variant (Variation ID: 10858). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt OCRL protein function with a positive predictive value of 95%. For these reasons, this variant has been classified as Pathogenic.
not provided Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at